https://www.selleckchem.com/pr....oducts/palazestrant.
patients with manifest cardiovascular disease.The concepts and elements determining quality of care at the End of Life may vary across professional groups but there is consensus that high-quality care at the End of Life is beneficial for the patient, families, health systems and society at large. This scoping review aimed to elucidate gaps in the delivery of this specific type of care in older people from the clinicians' perspective, and to identify potential solutions to both improve this care and promote work satisfaction by the
Gefällt mir
Kommentar
Teilen
